Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand

PloS One
Natalie GauldStephen Buetow

Abstract

Despite similarities in health systems and Trans-Tasman Harmonization of medicines scheduling, New Zealand is more active than Australia in 'switching' (reclassifying) medicines from prescription to non-prescription. To identify and compare enablers and barriers to switch in New Zealand and Australia. We conducted and analyzed 27 in-depth personal interviews with key participants in NZ and Australia and international participants previously located in Australia, and analyzed records of meetings considering switches (2000-2013). Analysis of both sets of data entailed a heuristic qualitative approach that embraced the lead researcher's knowledge and experience. The key themes identified were conservatism and political influences in Australia, and an open attitude, proactivity and flexibility in NZ. Pharmacist-only medicine schedules and individuals holding a progressive attitude were proposed to facilitate switch in both countries. A pharmacy retail group drove many switches in NZ ('third-party switch'), unlike Australia. Barriers to switch in both countries included small market sizes, funding of prescription medicines and cost of doctor visits, and lack of market exclusivity. In Australia, advertising limitations for pharmacist...Continue Reading

References

May 8, 1992·Long Range Planning·A Demb, F F Neubauer
Sep 15, 2001·The New England Journal of Medicine·E P Brass
Sep 17, 2003·American Journal of Therapeutics·Joshua Cohen
Oct 22, 2004·Kidney International·Philip A McFarlane, Ahmed M Bayoumi
Feb 7, 2008·Spine·Rhoda ReardonUNKNOWN Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders
Aug 27, 2009·Organic & Biomolecular Chemistry·Anthony P Davis
Oct 22, 2009·The Annals of Pharmacotherapy·Fiona S KellyShalom I Benrimoj
Jan 1, 2009·The British Journal of Radiology·P R Hoskins, D Hardman
Jun 5, 2010·Sexually Transmitted Infections·Nicola Low, Jane Hocking
Nov 6, 2010·The Journal of Antimicrobial Chemotherapy·Natalie GauldJohn Shaw
Feb 18, 2011·The Annals of Pharmacotherapy·Carl R SchneiderRhonda M Clifford
Sep 13, 2011·Journal of Clinical Pharmacology·Eric P Brass, William R Hiatt
May 15, 2012·Clinical Therapeutics·Natalie GauldStephen Buetow
Sep 6, 2012·The Journal of Antimicrobial Chemotherapy·Natalie J GauldQ Sue Huang
Feb 9, 2013·Journal of Health Services Research & Policy·Ruth EndacottValerie Woodward
Aug 21, 2013·The International Journal of Pharmacy Practice·Krishneeta C KashyapGreg Kyle
Jan 15, 2014·Journal of the Royal Army Medical Corps·Neale Piper, D Lamb

❮ Previous
Next ❯

Citations

Jul 15, 2015·Journal of Health Services Research & Policy·Natalie GauldStephen Buetow
Oct 26, 2018·Journal of Health Services Research & Policy·Amary MeyDenise Hope
Jan 9, 2020·The International Journal of Pharmacy Practice·Denise L HopeMichelle A King
Jul 14, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Natalie Gauld, Tracey Sullivan
Dec 5, 2020·Risk Management and Healthcare Policy·Doungporn LeelavanichPuree Anantachoti

❮ Previous
Next ❯

Software Mentioned

Tasman
Trans
NVIVO

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.